Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

298 projects

  • Effect of antidiabetic drug on brown adipose tissue in overweight men

    Brown adipose tissue (BAT) activation by Sitagliptin; a novel treatment strategy to combat metabolic disease.
  • Imaging in LifeLines (part 1)

    The Imalife study: to assess reference values of lung density, bronchial wall thickness, vascular calcification and lung nodules.
  • Reducing microvascular injury in myocardial infarction.

    Reduce microvascular injury in patients with myocardial infarction by off-target properties of the medicine ticagrelor.
  • Tool to predict target-related adverse effects of biological drugs

    Earlier access to innovative and safer drugs, by predicting target-related adverse effects of biological drugs.